Literature DB >> 20126967

Comparison of diet quality, physical activity and biochemical values of older adults either reporting or not reporting use of lipid-lowering medication.

I Lofgren1, G Greene, S Schembre, M J Delmonico, D Riebe, P Clark.   

Abstract

OBJECTIVES: The aim of this study was to compare standard lipid profile, reported dietary intake, and physical activity in older adults who reported taking or not taking a lipid-lowering medication, namely statins.
DESIGN: Cross-sectional study utilizing baseline data collected from a subsample of a larger randomized clinical trial, The Study of Exercise and Nutrition in Older Rhode Islanders (SENIOR) Project. PARTICIPANTS AND
SETTING: A total of 115 participants, 33 males and 82 females, over the age of 60, community-dwelling, primarily retired, and from East Providence, Rhode Island and surrounding communities in Rhode Island and Massachusetts. MEASUREMENTS: Height and weight were measured and used to calculate body mass index. Waist circumference was measured. Medical history and medication use surveys were completed. Dietary assessment was done via three 24 hour recalls using NDS-R. The Yale Physical Activity Survey was used to determine energy expenditure during exercise and a physical activity summary score. Fasting blood samples were obtained to determine lipid profile.
RESULTS: 37 participants (32.2%) reported taking lipid-lowering medication, statins exclusively, and 78 (67.8%) reported not taking any lipid-lowering medication. Participants who reported taking statins had better lipid profiles than those participants who reported not taking statins but had significantly lower intakes of vitamin B12, vitamin K, calcium, and potassium. There were no differences between groups on reported physical activity. However, the mean intakes for both groups did not meet the Dietary Reference Intakes for multiple nutrients.
CONCLUSION: Older adults need additional education on the importance of lifestyle changes in reducing CHD risk, whether taking lipid-lowering medications or not.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20126967      PMCID: PMC3832183          DOI: 10.1007/s12603-010-0030-0

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  28 in total

1.  An evaluation of three self-report physical activity instruments for older adults.

Authors:  N D Harada; V Chiu; A C King; A L Stewart
Journal:  Med Sci Sports Exerc       Date:  2001-06       Impact factor: 5.411

2.  Dietary indiscretion and statin use.

Authors:  Devin M Mann; John P Allegrante; Sundar Natarajan; Victor M Montori; Ethan A Halm; Mary Charlson
Journal:  Mayo Clin Proc       Date:  2007-08       Impact factor: 7.616

3.  Position of the American Dietetic Association: weight management.

Authors:  Helen M Seagle; Gladys Witt Strain; Angela Makris; Rebecca S Reeves
Journal:  J Am Diet Assoc       Date:  2009-02

4.  A comparison of the Yale Physical Activity Survey with other physical activity measures.

Authors:  D R Young; S H Jee; L J Appel
Journal:  Med Sci Sports Exerc       Date:  2001-06       Impact factor: 5.411

5.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

6.  A survey for assessing physical activity among older adults.

Authors:  L Dipietro; C J Caspersen; A M Ostfeld; E R Nadel
Journal:  Med Sci Sports Exerc       Date:  1993-05       Impact factor: 5.411

7.  Sources of folate and serum folate levels in older adults.

Authors:  Jessica E Mulligan; Geoffrey W Greene; Marjorie Caldwell
Journal:  J Am Diet Assoc       Date:  2007-03

Review 8.  Medication nonadherence: an unrecognized cardiovascular risk factor.

Authors:  Mark A Munger; Benjamin W Van Tassell; Joanne LaFleur
Journal:  MedGenMed       Date:  2007-09-19

9.  Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure.

Authors:  L I Gidez; G J Miller; M Burstein; S Slagle; H A Eder
Journal:  J Lipid Res       Date:  1982-11       Impact factor: 5.922

10.  Descriptive study of lipid-modulating drug use in a French professional population.

Authors:  E F Boumendil
Journal:  J Clin Epidemiol       Date:  1994-10       Impact factor: 6.437

View more
  5 in total

1.  Different time trends of caloric and fat intake between statin users and nonusers among US adults: gluttony in the time of statins?

Authors:  Takehiro Sugiyama; Yusuke Tsugawa; Chi-Hong Tseng; Yasuki Kobayashi; Martin F Shapiro
Journal:  JAMA Intern Med       Date:  2014-07       Impact factor: 21.873

2.  A content analysis of the representation of statins in the British newsprint media.

Authors:  Julia Chisnell; Tom Marshall; Chris Hyde; Zhivko Zhelev; Lora E Fleming
Journal:  BMJ Open       Date:  2017-08-21       Impact factor: 2.692

3.  Association between Dietary Intake and Lipid-Lowering Therapy: Prospective Analysis of Data from Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) Using a Quantile Regression Approach.

Authors:  Adelle M Gadowski; Natalie Nanayakkara; Stephane Heritier; Dianna J Magliano; Jonathan E Shaw; Andrea J Curtis; Sophia Zoungas; Alice J Owen
Journal:  Nutrients       Date:  2019-08-09       Impact factor: 5.717

4.  Comparing the Trend of Physical Activity and Caloric Intake between Lipid-Lowering Drug Users and Nonusers among Adults with Dyslipidemia: Korean National Health and Nutrition Examination Surveys (2010-2013).

Authors:  Jin-Young Oh; Lan Chekal; Se-Won Kim; Jee-Yon Lee; Duk-Chul Lee
Journal:  Korean J Fam Med       Date:  2016-03-25

5.  Comparison of Food and Nutrient Intakes between Japanese Dyslipidemic Patients with and without Low-Density Lipoprotein Cholesterol Lowering Drug Therapy: A Cross-Sectional Study.

Authors:  Noriko Kameyama; Chizuko Maruyama; Yuri Shijo; Ariko Umezawa; Aisa Sato; Makoto Ayaori; Katsunori Ikewaki; Masako Waki; Tamio Teramoto
Journal:  J Atheroscler Thromb       Date:  2019-10-03       Impact factor: 4.928

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.